| HOME >> MEDICINE >> TECHNOLOGY |
$ 4,354$ 4,026 Claims and discounts payable
2,7762,569 Accrued expenses
3,2293,070 Short-term debt
300300 Current portion of long-term debt
8061,105Total current liabilities
11,46511,070 Long-term debt
8,6698,652 Deferred income taxes
3,7103,655 Other long-term liabilities
1,0321,058 Commitments and contingencies Redeemable noncontrolling interest
3334Shareholders' equity:Preferred stock, par value $0.01: 0.1 shares authorized; none issued or
outstanding
——Common stock, par value $0.01: 3,200 shares authorized; 1,627 shares
issued and 1,354 shares outstanding at March 31, 2011 and 1,624
shares issued and 1,363 shares outstanding at December 31, 2010Treasury stock, at cost: 271 shares at March 31, 2011 and 259 shares
at December 31, 2010(9,449)(9,030)Shares held in trust: 2 shares at March 31, 2011 and December 31,
2010
(56)(56)Capital surplus
27,70627,610Retained earnings
19,84519,303Accumulated other comprehensive loss
(143)(143)Total shareholders' equity
37,91937,700Total liabilities and shareholders' equity
$ 62,828$ 62,169CVS CAREMARK CORPORATIONCondensed Consolidated Statements of Cash Flows(Unaudited) Three Months Ended March 31,In millions
20112010Cash flows from operating activities: Cash receipts from revenues
$ 22,971$ 22,918 Cash paid for inventory and prescriptions dispensed by retail network pharmacies
(17,445)(17,581) Cash paid to other suppliers and employees
(3,342)(3,916) Interest received
11 Interest paid
(150)(155) Income taxes paid
(169)(207)Net cash provided by operating activities
1,8661,060Cash flows from investing activities: Purchases of property and equipment
(309)(401) Proceeds fro
'/>"/>
| SOURCE CVS Caremark Corporation Copyright©2010 PR Newswire. All rights reserved |